DE | EN

Andre Schreiber, Msc

Current affiliations

Institute of Molecular Virology

Publications

The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.

Schreiber A; Rodner F; Oberberg N; Anhlan D; Bletz S; Mellmann A; Planz O; Ludwig S (2024)

In: Antiviral Research, 225, 105840-105840. doi:10.1016/j.antiviral.2024.105840

Research article (journal) | Peer reviewed | Published

The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus

Nacken, Wolfgang; Schreiber, André; Masemann, Dörthe; Ludwig, Stephan (2021)

In: mBio, 12(5), e021962. doi:10.1128/mBio.02196-21

Research article (journal) | Peer reviewed | Published

Prizes

Dissertation Prize of the Faculty of Biology of the University of Münster
Awarded by: University of Münster
Award given to: Schreiber, Andre
Announced at: 10/11/2020 | Date of awarding: 15/12/2020
Type of distinction: Research award or other distinction